Abbonarsi

Covered versus uncovered self-expandable metallic stents for palliation of malignant pyloric obstruction in gastric cancer patients: a randomized, prospective study - 24/08/11

Doi : 10.1016/j.gie.2010.01.039 
Chan Gyoo Kim, MD, PhD, Il Ju Choi, MD, PhD , Jong Yeul Lee, MD, Soo-Jeong Cho, MD, PhD, Sook Ryun Park, MD, PhD, Jun Ho Lee, MD, PhD, Keun Won Ryu, MD, PhD, Young-Woo Kim, MD, PhD, Young Iee Park, MD, PhD
Current affiliations: Center for Gastric Cancer, National Cancer Center, Goyang, Korea 

Reprint requests: Il Ju Choi, MD, PhD, Center for Gastric Cancer, National Cancer Center, 111 Jungbalsan-ro, Ilsandong-gu, Goyang, Gyeonggi, 410-769, Korea

Riassunto

Background

Self-expandable metallic stents (SEMSs) provide effective palliation of malignant pyloric obstruction in patients with inoperable gastric cancer.

Objective

To compare the effectiveness and side effects of covered and uncovered SEMSs for the palliation of malignant pyloric obstruction.

Design

Prospective, randomized, single-center study.

Setting

Tertiary-care cancer center hospital.

Patients

This study involved 80 patients with pyloric obstruction related to inoperable gastric cancer.

Intervention

Covered or uncovered SEMS placement.

Main Outcome Measurements

Technical and clinical success rates as well as the patency rate at 8 weeks after placement.

Results

Both groups had a technical success rate of 100% with no immediate complications. Both groups also had comparable clinical success rates (covered SEMS, 95% [38 of 40] and uncovered SEMS, 90% [36 of 40], P = .68) and 8-week patency rates (covered SEMS, 61.3% [19 of 31] and uncovered SEMS, 61.1% [22 of 36], P > .99). Stent migration within 8 weeks was more common in the covered SEMS group (25.8% [8 of 31]) than in the uncovered SEMS group (2.8% [1 of 36], P = .009), whereas re-stenosis because of tumor ingrowth was more common in the uncovered SEMS group (25.0% [9 of 36] vs 0% [0 of 31] in the covered SEMS group, P = .003). Overall patient survival and stent patency did not differ between groups (P = .27 and 0.61 by log-rank test, respectively).

Limitations

The study population was limited to gastric cancer patients, and stent designs were changed in the midst of the study period.

Conclusion

Both the covered and uncovered SEMSs are effective and have comparable 8-week patency in patients with malignant pyloric obstruction, despite different patterns of late stent failure.

Il testo completo di questo articolo è disponibile in PDF.

Abbreviations : GOO, GOOSS, SEMS


Mappa


 DISCLOSURE: All authors disclosed no financial relationships relevant to this publication. Dr Il Ju Choi was supported by grant 0910090 from the National Cancer Center, Korea.
 See CME section; p. 177
 If you would like to chat with an author of this article, you may contact Dr Choi at cij1224@hanmail.net.


© 2010  American Society for Gastrointestinal Endoscopy. Pubblicato da Elsevier Masson SAS. Tutti i diritti riservati.
Aggiungere alla mia biblioteca Togliere dalla mia biblioteca Stampare
Esportazione

    Citazioni Export

  • File

  • Contenuto

Vol 72 - N° 1

P. 25-32 - luglio 2010 Ritorno al numero
Articolo precedente Articolo precedente
  • Preliminary accuracy and interobserver agreement for the detection of intraepithelial neoplasia in Barrett's esophagus with probe-based confocal laser endomicroscopy
  • Michael B. Wallace, Prateek Sharma, Charles Lightdale, Herbert Wolfsen, Emmanuel Coron, Anna Buchner, Monther Bajbouj, Ajay Bansal, Amit Rastogi, Julian Abrams, Julia E. Crook, Alexander Meining
| Articolo seguente Articolo seguente
  • Cost-effectiveness of endoscopic surveillance of gastric ulcers to improve survival
  • Jennifer M. Yeh, Wendy Ho, Chin Hur

Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.

Già abbonato a @@106933@@ rivista ?

@@150455@@ Voir plus

Il mio account


Dichiarazione CNIL

EM-CONSULTE.COM è registrato presso la CNIL, dichiarazione n. 1286925.

Ai sensi della legge n. 78-17 del 6 gennaio 1978 sull'informatica, sui file e sulle libertà, Lei puo' esercitare i diritti di opposizione (art.26 della legge), di accesso (art.34 a 38 Legge), e di rettifica (art.36 della legge) per i dati che La riguardano. Lei puo' cosi chiedere che siano rettificati, compeltati, chiariti, aggiornati o cancellati i suoi dati personali inesati, incompleti, equivoci, obsoleti o la cui raccolta o di uso o di conservazione sono vietati.
Le informazioni relative ai visitatori del nostro sito, compresa la loro identità, sono confidenziali.
Il responsabile del sito si impegna sull'onore a rispettare le condizioni legali di confidenzialità applicabili in Francia e a non divulgare tali informazioni a terzi.


Tutto il contenuto di questo sito: Copyright © 2026 Elsevier, i suoi licenziatari e contributori. Tutti i diritti sono riservati. Inclusi diritti per estrazione di testo e di dati, addestramento dell’intelligenza artificiale, e tecnologie simili. Per tutto il contenuto ‘open access’ sono applicati i termini della licenza Creative Commons.